NO20091975L - Micellar nanoparticles of chemical substances - Google Patents

Micellar nanoparticles of chemical substances

Info

Publication number
NO20091975L
NO20091975L NO20091975A NO20091975A NO20091975L NO 20091975 L NO20091975 L NO 20091975L NO 20091975 A NO20091975 A NO 20091975A NO 20091975 A NO20091975 A NO 20091975A NO 20091975 L NO20091975 L NO 20091975L
Authority
NO
Norway
Prior art keywords
micelles
chemical substances
micellar nanoparticles
solid composition
preparing
Prior art date
Application number
NO20091975A
Other languages
Norwegian (no)
Inventor
Jan P Moschwitzer
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20091975L publication Critical patent/NO20091975L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

Den foreliggende oppfinnelsen er relatert til en termostabil fast sammensetning inneholdende miceller av nanostørrelse, hvor micellene inneholder en dårlig løselig kjemisk substans, slik som en biologisk aktiv substans, er løst opp i et hjelpemateriale, og micellene er pakket inn i en vannløselig bærer. Oppfinnelsen er videre relatert til en fremgangsmåte for å fremstille en termostabil fast sammensetning og til en fremgangsmåte for å fremstille farmasøytiske doseringsformer omfattende det samme.The present invention relates to a thermostable solid composition containing nano-sized micelles, wherein the micelles contain a poorly soluble chemical, such as a biologically active substance, dissolved in an auxiliary material, and the micelles are wrapped in a water-soluble carrier. The invention is further related to a process for preparing a thermostable solid composition and to a process for preparing pharmaceutical dosage forms comprising the same.

NO20091975A 2006-10-20 2009-05-20 Micellar nanoparticles of chemical substances NO20091975L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85302306P 2006-10-20 2006-10-20
EP06122648 2006-10-20
PCT/EP2007/061194 WO2008046905A1 (en) 2006-10-20 2007-10-19 Micellar nanoparticles of chemical substances

Publications (1)

Publication Number Publication Date
NO20091975L true NO20091975L (en) 2009-07-09

Family

ID=38661928

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091975A NO20091975L (en) 2006-10-20 2009-05-20 Micellar nanoparticles of chemical substances

Country Status (9)

Country Link
EP (1) EP2083799A1 (en)
JP (1) JP5439182B2 (en)
KR (1) KR101434334B1 (en)
AU (1) AU2007312233B2 (en)
CA (1) CA2666587C (en)
EA (1) EA026213B1 (en)
IL (1) IL197701A (en)
NO (1) NO20091975L (en)
WO (1) WO2008046905A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR071375A1 (en) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh FORMULATIONS FOR ACTIVE PHARMACEUTICAL INGREDIENTS OF DEFICIENT PERMEABILITY, PREPARATION AND PRODUCT PROCESS
KR20110056516A (en) 2008-09-12 2011-05-30 크리티컬 파머수티컬스 리미티드 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
AR075180A1 (en) * 2009-01-29 2011-03-16 Novartis Ag SOLID ORAL FORMULATIONS OF A PYRIDOID-PYRIMIDINONE
EP2841090A1 (en) * 2012-04-24 2015-03-04 Amylin Pharmaceuticals, LLC Site-specific enzymatic modification of exendins and analogs thereof
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
FR3014317B1 (en) * 2013-12-11 2016-04-22 Patrice Binay NOVEL PROCESS FOR THE PRODUCTION OF TRANSMUCAL PHARMACEUTICAL FORMULATIONS AND FORMATIONS THUS OBTAINED
EP3424493A1 (en) * 2017-07-07 2019-01-09 SolMic Research GmbH Stable cannabinoid compositions
WO2020107119A1 (en) * 2018-11-30 2020-06-04 Canopy Growth Corporation Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use
EP4005561A4 (en) * 2019-07-25 2022-12-07 Beijing Shenogen Pharma Group Ltd. Nano-micelle preparation of icaritin and preparation method therefor and application thereof
CN112915121A (en) 2019-12-06 2021-06-08 汉义生物科技（北京）有限公司 Cannabinoid nano micelle preparation and preparation method thereof
EP4072516A1 (en) 2019-12-09 2022-10-19 Nicoventures Trading Limited Oral product comprising a cannabinoid
AU2022315590A1 (en) * 2021-07-22 2024-01-18 Nicoventures Trading Limited Composition comprising a constituent, derivative or extract of cannabis
CA3225822A1 (en) * 2021-07-22 2023-01-26 Steven Alderman Compositions comprising constituents, derivatives or extracts of cannabis
WO2023002197A1 (en) * 2021-07-22 2023-01-26 Nicoventures Trading Limited Compositions comprising a constituent, derivative or extract of cannabis
IL309703A (en) * 2021-07-22 2024-02-01 Nicoventures Trading Ltd Constituent, derivative or extract of cannabis in a water soluble matrix

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
FR2804604B1 (en) * 2000-02-09 2005-05-27 Sanofi Synthelabo USE OF A CENTRAL CANNABINOID RECEPTOR ANTAGONIST FOR THE PREPARATION OF USEFUL DRUGS TO FACILITATE THE STOPPAGE OF TOBACCO CONSUMPTION
MXPA03009439A (en) * 2001-09-21 2004-02-12 Solvay Pharm Bv 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity.
CA2456606C (en) * 2001-09-21 2010-01-26 Solvay Pharmaceuticals B.V. 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
GB0305941D0 (en) * 2003-03-14 2003-04-23 Camurus Ab Composition
US20050096365A1 (en) * 2003-11-03 2005-05-05 David Fikstad Pharmaceutical compositions with synchronized solubilizer release
JP4994039B2 (en) * 2003-11-26 2012-08-08 スパーナス ファーマシューティカルズ インコーポレイテッド Micellar system useful for delivery of lipophilic or hydrophobic compounds
WO2005053727A2 (en) * 2003-11-29 2005-06-16 Sangstat Medical Corporation Pharmaceutical compositions for bioactive peptide agents
KR20060123493A (en) * 2003-12-23 2006-12-01 알자 코포레이션 Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
TW200529890A (en) * 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
CA2585175A1 (en) * 2004-10-25 2006-05-04 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions
ES2545589T3 (en) * 2005-04-08 2015-09-14 Abbott Laboratories Oral pharmaceutical formulations comprising salts of fenofibric acid
JP2008536929A (en) * 2005-04-18 2008-09-11 ルビコン・リサーチ・ピーヴィーティー・エルティーディー Bio-enhancing composition

Also Published As

Publication number Publication date
IL197701A0 (en) 2009-12-24
CA2666587A1 (en) 2008-04-24
CA2666587C (en) 2015-12-22
JP5439182B2 (en) 2014-03-12
EA200900572A1 (en) 2009-10-30
WO2008046905A1 (en) 2008-04-24
AU2007312233A1 (en) 2008-04-24
EA026213B1 (en) 2017-03-31
IL197701A (en) 2014-12-31
KR20090077074A (en) 2009-07-14
KR101434334B1 (en) 2014-08-28
EP2083799A1 (en) 2009-08-05
AU2007312233B2 (en) 2012-09-20
JP2010506886A (en) 2010-03-04

Similar Documents

Publication Publication Date Title
NO20091975L (en) Micellar nanoparticles of chemical substances
MX2010011564A (en) Improved formulations for poorly permeable active pharmaceutical ingredients.
BRPI0508579A (en) compound, pharmaceutical composition, and use of a compound
EA200870219A1 (en) STABILIZED WITH VITAMIN E SUCCINAT PHARMACEUTICAL COMPOSITIONS, METHODS FOR THEIR PRODUCTION AND USE
TW200640502A (en) Tablets with improved drug substance dispersibility
GT200500045A (en) STABILIZED SUPERSATURED SOLIDS OF LIPOFILIC DRUGS
AR063587A1 (en) LIQUID PREPARATION UNDERSTANDING PIMOBENDAN
PL1962815T3 (en) Use of film-forming hair-care polymers from the group of polyurethanes and pharmaceutical preparations and plasters containing said polymers
ES2722201T3 (en) Compositions and procedures useful for stabilizing protein-containing formulations
CY1110037T1 (en) PACKAGES FOR BENZIMIDAZOLYL PYRIDYL ETHERS
MXPA05011076A (en) Chemical compounds.
TR200806298A2 (en) Pharmaceutical formulation
BRPI0719277A2 (en) CONCENTRATED PHYTOSANITARY FORMULATION, USING FORMULATION AND SOLVENT COMPOSITION UNDERSTANDING A SOLVENT MIX
UA86441C2 (en) (2-hydroxyethyl)trimethylammonium thiooctate (choline thioctate), having hepatoprotective, hypoamoniemic and detoxic action, method for production thereof and pharmaceutical compositions based on it
RU2012127776A (en) SOLUBLE FILMS CONTAINING HIGH CONCENTRATIONS OF NON-ION SURFACE-ACTIVE SUBSTANCES SUCH AS POLYSORBATES TO INCREASE HIGH LOADS OF SOLID PRODUCTS
NO20084478L (en) Conjugated Lipid Derivatives
TW200628468A (en) Bicyclononene derivatives
MX2009004124A (en) Micellar nanoparticles of chemical substances.
HK1120417A1 (en) Stable nanoparticle formulations
UY30126A1 (en) A NEW PHARMACEUTICALLY ACCEPTABLE SALT OF 2-HIDROXI-3- (5- (MORFOLIN-4-ILMETIL) -PIRIDIN-2-L) 1H-INDOL-5-CARBONITRILE, PROCEDURES FOR THE PREPARATION, COMPOSITIONS CONTAINING IT AND APPLICATIONS
EA201390911A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING PLANT ACTIVE SUBSTANCE
GB0615105D0 (en) Novel compounds
TW200637826A (en) Chemical compounds
UA93190C2 (en) Naphthalene compounds, a process for their preparation and pharmaceutical compositions containing them
TR200601092T1 (en) New oral pharmaceutical formulations containing the active ingredient irbesartan.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application